A Shift in Focus: The New MASH Classification and Its Impact on Treatment
Understanding the Transition from NASH to MASH The field of liver disease has undergone a major transformation with the reclassification of Nonalcoholic Steatohepatitis (NASH) to Metabolic Dysfunction-Associated Steatohepatitis (MASH). This change better reflects the disease’s strong link to metabolic disorders such as obesity, diabetes, and